Search results
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
Reuters· 7 hours agoCOVID-19 vaccine makers said data from animals studies showed their 2024-25 shots targeting the JN.1...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 2 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna director Noubar Afeyan sells shares worth over $2.9 million By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a total of $2,901,584 worth of company...
Moderna's RSV vaccine for older adults approved
Axios· 5 days agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...
Will there be a new Covid vaccine in the fall?
AOL· 36 minutes agoAlthough Covid cases remain low in the U.S., vaccine experts are already looking toward the winter, with eyes on preventing a seasonal surge. A Food and Drug Administration advisory panel on ...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 2 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 2 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 2 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
